Botanical species · safety record

Lycopodium japonicum

The EFSA Compendium of Botanicals holds 6 constituent measurements for Lycopodium japonicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lycopodium japonicum Thunb.

6Constituent measurements

0Safety records

6Cited sources

45Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 45 licensed products naming Lycopodium japonicum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Herb
Herb(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Live plants	Solvent extraction	0.459 Percent	Unspecified	Resolve DOI
Alkaloids	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lycodine	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lycopodine	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Physcion	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang, Xiao-Jing., Liu, Yun-Bao., Li, Li., Yu, Shi-Shan., Lv, Hai-Ning., Ma, Shuang-Gang., Bao, Xiu-Qi., Zhang, Dan., Qu, Jing., Li, Yong. Lycojaponicumins D and E: Two New Alkaloids from Lycopodium japonicum. ORGANIC LETTERS, 2012, vol. 14, no. 22, p. 5688-5691. DOI
He, Juan., Wu, Xing-De., Liu, Fei., Liu, Yu-Cheng., Peng, Li-Yan., Zhao, Yu., Cheng, Xiao., Luo, Huai-Rong., Zhao, Qin-Shi. Lycopodine-Type Alkaloids from Lycopodium japonicum.. Natural products and bioprospecting, 2014, vol. 4, no. 4, p. 213-9. DOI
Yang, Z., Zhang, D., Ren, J., Yang, M., Li, S. Acetylcholinesterase inhibitory activity of the total alkaloid from traditional Chinese herbal medicine for treating Alzheimer's disease. Medicinal chemistry research, 2012, vol. 21, no. 6, p. 734-738. DOI
Sun, Yun., Yan, Jian., Meng, Hao., He, Chun-Lin., Yi, Ping., Qiao, Ying., Qiu, Ming-Hua. A New Alkaloid from Lycopodium japonicum THUNB.. HELVETICA CHIMICA ACTA, 2008, vol. 91, no. 11, p. 2107-2109. DOI
Wu, Jichun., Wang, Huanqin., Ma, Yanfang., Jiang, Jinhe., Zhan, Rui., Chen, Yegao. Isolation of a new lycodine alkaloid from Lycopodium japonicum. NATURAL PRODUCT RESEARCH, 2015, vol. 29, no. 8, p. 735-738. DOI
Cai, X., Pan, D., Chen, Y., Wu, W., Liu, X. The isolation and identification of the anthraquinones from Lycopodium japonicum L. and Lycopodium obscurum L. Acta academiae medicinae shanghai, 1991, vol. 18, no. 5, p. 383-385.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature